November 2015 Analysis

Pages

Industry Trend Analysis - Pfizer-Allergan Tax Inversion To Close Despite Opposition - 30 NOV 2015

Pfizer's controversial 'tax inversion' of Allergan is likely to close despite bipartisan annoyance at the deal, which will deprive the US Treasury of billions of dollars in taxes over the next few years. It is too late for Congress to pass legislation to prevent such deals before the 2016 presidential election. While the government has the authority to implement retroactive changes to the rules...

READ FULL ARTICLE

Pages